Literature DB >> 16081833

Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation.

Maud M Gueders1, Milagros Balbin, Natacha Rocks, Jean-Michel Foidart, Philippe Gosset, Renaud Louis, Steven Shapiro, Carlos Lopez-Otin, Agnes Noël, Didier D Cataldo.   

Abstract

Matrix metalloproteinases (MMPs) are involved in inflammatory reaction, including asthma-related airway inflammation. MMP-8, mainly produced by neutrophils, has recently been reported to be increased in the bronchoalveolar lavage fluid (BALF) from asthmatic patients. To evaluate the role of MMP-8 in asthma, we measured MMP-8 expression in lung tissue in an OVA-sensitized mouse model of asthma and addressed the effect of MMP-8 deletion on allergen-induced bronchial inflammation. MMP-8 production was increased in lungs from C57BL/6 mice exposed to allergens. After allergen exposure, MMP-8(-/-) mice developed an airway inflammation characterized by an increased neutrophilic inflammation in BALF and an increased neutrophilic and eosinophilic infiltration in the airway walls. MMP-8 deficiency was associated with increased levels of IL-4 and anti-OVA IgE and IgG1 in BALF and serum, respectively. Although allergen exposure induced an enhancement of LPS-induced CXC chemokine, KC, and MIP-2 levels in BALF and lung parenchyma, no difference was observed between the two genotypes. Inflammatory cell apoptosis was reduced in the lungs from MMP-8(-/-) mice. For the first time, our study evidences an important role of MMP-8 in the control of neutrophilic and eosinophilic infiltration during allergen-induced lung inflammation, and demonstrates that the anti-inflammatory effect of MMP-8 is partly due to a regulation of inflammatory cell apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16081833     DOI: 10.4049/jimmunol.175.4.2589

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  47 in total

1.  Substance P in polymicrobial sepsis: molecular fingerprint of lung injury in preprotachykinin-A-/- mice.

Authors:  Akhil Hegde; Ramasamy Tamizhselvi; Jayapal Manikandan; Alirio J Melendez; Shabbir M Moochhala; Madhav Bhatia
Journal:  Mol Med       Date:  2010-02-08       Impact factor: 6.354

2.  Comparison of rapid MMP-8 and interleukin-6 point-of-care tests to identify intra-amniotic inflammation/infection and impending preterm delivery in patients with preterm labor and intact membranes.

Authors:  Piya Chaemsaithong; Roberto Romero; Nikolina Docheva; Noppadol Chaiyasit; Gaurav Bhatti; Percy Pacora; Sonia S Hassan; Lami Yeo; Offer Erez
Journal:  J Matern Fetal Neonatal Med       Date:  2017-03-01

Review 3.  Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted.

Authors:  Kendra J Greenlee; Zena Werb; Farrah Kheradmand
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

4.  Expression of ADAMs and their inhibitors in sputum from patients with asthma.

Authors:  Geneviève Paulissen; Natacha Rocks; Florence Quesada-Calvo; Philippe Gosset; Jean-Michel Foidart; Agnès Noel; Renaud Louis; Didier D Cataldo
Journal:  Mol Med       Date:  2006 Jul-Aug       Impact factor: 6.354

5.  Matrix metalloproteinase 8 contributes to solubilization of IL-13 receptor alpha2 in vivo.

Authors:  Weiguo Chen; Yasuhiro Tabata; Aaron M Gibson; Michael O Daines; Manoj R Warrier; Marsha Wills-Karp; Gurjit K Khurana Hershey
Journal:  J Allergy Clin Immunol       Date:  2008-08-09       Impact factor: 10.793

6.  IL-13R alpha 2 membrane and soluble isoforms differ in humans and mice.

Authors:  Weiguo Chen; Umasundari Sivaprasad; Yasuhiro Tabata; Aaron M Gibson; Matthew T Stier; Fred D Finkelman; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

7.  Tissue inhibitor of metalloproteinase-1 modulates allergic lung inflammation in murine asthma.

Authors:  Mark F Sands; Patricia J Ohtake; Supriya D Mahajan; Shervin S Takyar; Ravikumar Aalinkeel; Yisheng V Fang; Jessica W Blume; Barbara A Mullan; Don E Sykes; Sandra Lachina; Paul R Knight; Stanley A Schwartz
Journal:  Clin Immunol       Date:  2008-10-26       Impact factor: 3.969

8.  Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury.

Authors:  Vanessa J Craig; Pablo A Quintero; Susanne E Fyfe; Avignat S Patel; Martin D Knolle; Lester Kobzik; Caroline A Owen
Journal:  J Immunol       Date:  2013-03-13       Impact factor: 5.422

Review 9.  Roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

Review 10.  Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics.

Authors:  Björn Pasternak; Per Aspenberg
Journal:  Acta Orthop       Date:  2009-12       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.